|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vincent A, Herman J, Schulick R, Hruban RH
and Goggins M: Pancreatic cancer. Lancet. 378:607–620. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gall TM, Tsakok M, Wasan H and Jiao LR:
Pancreatic cancer: Current management and treatment strategies.
Postgrad Med J. 91:601–607. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Díaz Osterman CJ, Gonda A, Stiff T,
Sigaran U, Valenzuela MM, Ferguson Bennit HR, Moyron RB, Khan S and
Wall NR: Curcumin induces pancreatic adenocarcinoma cell death via
reduction of the inhibitors of apoptosis. Pancreas. 45:101–109.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li W, Ma J, Ma Q, Li B, Han L, Liu J, Xu
Q, Duan W, Yu S, Wang F, et al: Resveratrol inhibits the
epithelial-mesenchymal transition of pancreatic cancer cells via
suppression of the PI-3K/Akt/NF-κB pathway. Curr Med Chem.
20:4185–4194. 2013. View Article : Google Scholar
|
|
6
|
Shanmugam MK, Rane G, Kanchi MM, Arfuso F,
Chinnathambi A, Zayed ME, Alharbi SA, Tan BK, Kumar AP and Sethi G:
The multifaceted role of curcumin in cancer prevention and
treatment. Molecules. 20:2728–2769. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bose S, Panda AK, Mukherjee S and Sa G:
Curcumin and tumor immune-editing: Resurrecting the immune system.
Cell Div. 10:62015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee DJ and Kang SW: Reactive oxygen
species and tumor metastasis. Mol Cells. 35:93–98. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nishikawa M, Hashida M and Takakura Y:
Catalase delivery for inhibiting ROS-mediated tissue injury and
tumor metastasis. Adv Drug Deliv Rev. 61:319–326. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li W, Ma Z, Ma J, Li X, Xu Q, Duan W, Chen
X, Lv Y, Zhou S, Wu E, et al: Hydrogen peroxide mediates
hyperglycemia-induced invasive activity via ERK and p38 MAPK in
human pancreatic cancer. Oncotarget. 6:31119–31133. 2015.PubMed/NCBI
|
|
11
|
Du Y, Long Q, Zhang L, Shi Y, Liu X, Li X,
Guan B, Tian Y, Wang X, Li L, et al: Curcumin inhibits
cancer-associated fibroblast-driven prostate cancer invasion
through MAOA/mTOR/HIF-1α signaling. Int J Oncol. 47:2064–2072.
2015.PubMed/NCBI
|
|
12
|
Wu WS, Wu JR and Hu CT: Signal cross talks
for sustained MAPK activation and cell migration: The potential
role of reactive oxygen species. Cancer Metastasis Rev. 27:303–314.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
14
|
Duan W, Chang Y, Li R, Xu Q, Lei J, Yin C,
Li T, Wu Y, Ma Q and Li X: Curcumin inhibits hypoxia inducible
factor-1α-induced epithelial-mesenchymal transition in HepG2
hepatocellular carcinoma cells. Mol Med Rep. 10:2505–2510.
2014.PubMed/NCBI
|
|
15
|
Lei J, Huo X, Duan W, Xu Q, Li R, Ma J, Li
X, Han L, Li W, Sun H, et al: α-Mangostin inhibits hypoxia-driven
ROS-induced PSC activation and pancreatic cancer cell invasion.
Cancer Lett. 347:129–138. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Youns M and Fathy GM: Upregulation of
extrinsic apoptotic pathway in curcumin-mediated antiproliferative
effect on human pancreatic carcinogenesis. J Cell Biochem.
114:2654–2665. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang T, Chen Z and Fang L: Curcumin
inhibits LPS-induced EMT through downregulation of NF-κB-Snail
signaling in breast cancer cells. Oncol Rep. 29:117–124. 2013.
|
|
18
|
Nagaraju GP, Zhu S, Ko JE, Ashritha N,
Kandimalla R, Snyder JP, Shoji M and El-Rayes BF: Antiangiogenic
effects of a novel synthetic curcumin analogue in pancreatic
cancer. Cancer Lett. 357:557–565. 2015. View Article : Google Scholar
|
|
19
|
Toden S, Okugawa Y, Jascur T, Wodarz D,
Komarova NL, Buhrmann C, Shakibaei M, Boland CR and Goel A:
Curcumin mediates chemosensitization to 5-fluorouracil through
miRNA-induced suppression of epithelial-to-mesenchymal transition
in chemoresistant colorectal cancer. Carcinogenesis. 36:355–367.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dhillon N, Aggarwal BB, Newman RA, Wolff
RA, Kunnumakkara AB, Abbruzzese JL, Ng CS, Badmaev V and Kurzrock
R: Phase II trial of curcumin in patients with advanced pancreatic
cancer. Clin Cancer Res. 14:4491–4499. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kanai M, Yoshimura K, Asada M, Imaizumi A,
Suzuki C, Matsumoto S, Nishimura T, Mori Y, Masui T, Kawaguchi Y,
et al: A phase I/II study of gemcitabine-based chemotherapy plus
curcumin for patients with gemcitabine-resistant pancreatic cancer.
Cancer Chemother Pharmacol. 68:157–164. 2011. View Article : Google Scholar
|
|
22
|
Kim JM, Noh EM, Kwon KB, Kim JS, You YO,
Hwang JK, Hwang BM, Kim BS, Lee SH, Lee SJ, et al: Curcumin
suppresses the TPA-induced invasion through inhibition of
PKCα-dependent MMP-expression in MCF-7 human breast cancer cells.
Phytomedicine. 19:1085–1092. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sun XD, Liu XE and Huang DS: Curcumin
reverses the epithelial-mesenchymal transition of pancreatic cancer
cells by inhibiting the Hedgehog signaling pathway. Oncol Rep.
29:2401–2407. 2013.PubMed/NCBI
|
|
24
|
Shakibaei M, Mobasheri A, Lueders C, Busch
F, Shayan P and Goel A: Curcumin enhances the effect of
chemotherapy against colorectal cancer cells by inhibition of NF-κB
and Src protein kinase signaling pathways. PLoS One. 8:e572182013.
View Article : Google Scholar
|
|
25
|
Lu Y, Wei C and Xi Z: Curcumin suppresses
proliferation and invasion in non-small cell lung cancer by
modulation of MTA1-mediated Wnt/β-catenin pathway. In Vitro Cell
Dev Biol Anim. 50:840–850. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li W, Cao L, Han L, Xu Q and Ma Q:
Superoxide dismutase promotes the epithelial-mesenchymal transition
of pancreatic cancer cells via activation of the
H2O2/ERK/NF-κB axis. Int J Oncol.
46:2613–2620. 2015.
|
|
27
|
Li W, Ma Q, Li J, Guo K, Liu H, Han L and
Ma G: Hyperglycemia enhances the invasive and migratory activity of
pancreatic cancer cells via hydrogen peroxide. Oncol Rep.
25:1279–1287. 2011.PubMed/NCBI
|
|
28
|
Iqbal M, Sharma SD, Okazaki Y, Fujisawa M
and Okada S: Dietary supplementation of curcumin enhances
antioxidant and phase II metabolizing enzymes in ddY male mice:
Possible role in protection against chemical carcinogenesis and
toxicity. Pharmacol Toxicol. 92:33–38. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Balogun E, Hoque M, Gong P, Killeen E,
Green CJ, Foresti R, Alam J and Motterlini R: Curcumin activates
the haem oxygenase-1 gene via regulation of Nrf2 and the
antioxidant-responsive element. Biochem J. 371:887–895. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee KH, Kim SW and Kim JR: Reactive oxygen
species regulate urokinase plasminogen activator expression and
cell invasion via mitogen-activated protein kinase pathways after
treatment with hepatocyte growth factor in stomach cancer cells. J
Exp Clin Cancer Res. 28:732009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gallelli L, Falcone D, Scaramuzzino M,
Pelaia G, D'Agostino B, Mesuraca M, Terracciano R, Spaziano G,
Maselli R, Navarra M, et al: Effects of simvastatin on cell
viability and proinflammatory pathways in lung adenocarcinoma cells
exposed to hydrogen peroxide. BMC Pharmacol Toxicol. 15:672014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Poudel B, Lee YM and Kim DK: DDR2
inhibition reduces migration and invasion of murine metastatic
melanoma cells by suppressing MMP2/9 expression through ERK/NF-κB
pathway. Acta Biochim Biophys Sin (Shanghai). 47:292–298. 2015.
View Article : Google Scholar
|
|
33
|
Li P, Xu Q, Zhang D, Li X, Han L, Lei J,
Duan W, Ma Q, Wu Z and Wang Z: Upregulated miR-106a plays an
oncogenic role in pancreatic cancer. FEBS Lett. 588:705–712. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen Y, Zheng L, Liu J, Zhou Z, Cao X, Lv
X and Chen F: Shikonin inhibits prostate cancer cells metastasis by
reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and
ROS/ERK1/2 pathways. Int Immunopharmacol. 21:447–455. 2014.
View Article : Google Scholar : PubMed/NCBI
|
